Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines
Gerard Godoy-Tena, Anis Barmada, Octavio Morante-Palacios, Carlos de la Calle-Fabregat, Ricardo Martins-Ferreira, Anna G. Ferreté-Bonastre, Laura Ciudad, Adolfo Ruiz-Sanmartín, Mónica Martínez-Gallo, Ricard Ferrer, Juan Carlos Ruiz-Rodriguez, Javier Rodríguez-Ubreva, Roser Vento-Tormo, View ORCID ProfileEsteban Ballestar
doi: https://doi.org/10.1101/2022.10.24.22281485
Gerard Godoy-Tena
1Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Anis Barmada
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1RQ, United Kingdom
3Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ, United Kingdom
Octavio Morante-Palacios
1Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Carlos de la Calle-Fabregat
1Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Ricardo Martins-Ferreira
1Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Anna G. Ferreté-Bonastre
1Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Laura Ciudad
1Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Adolfo Ruiz-Sanmartín
4Intensive Care Department, Vall d’Hebron University Hospital, Shock, Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
Mónica Martínez-Gallo
5Immunology Division, Vall d’Hebron University Hospital and Diagnostic Immunology Research Group, Vall d’Hebron Research Institute (VHIR), 08035 Barcelona, Spain
Ricard Ferrer
4Intensive Care Department, Vall d’Hebron University Hospital, Shock, Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
Juan Carlos Ruiz-Rodriguez
4Intensive Care Department, Vall d’Hebron University Hospital, Shock, Organ Dysfunction and Resuscitation (SODIR) Research Group, Vall d’Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
Javier Rodríguez-Ubreva
1Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Roser Vento-Tormo
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1RQ, United Kingdom
Esteban Ballestar
1Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
6Epigenetics in Inflammatory and Metabolic Diseases Laboratory, Health Science Center (HSC), East China Normal University (ECNU), Shanghai, 200241, China

Data Availability
DNA methylation data for this publication have been deposited in the NCBI Gene Expression Omnibus and are accessible through GEO SuperSeries accession number GSE188573.
Posted October 26, 2022.
Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines
Gerard Godoy-Tena, Anis Barmada, Octavio Morante-Palacios, Carlos de la Calle-Fabregat, Ricardo Martins-Ferreira, Anna G. Ferreté-Bonastre, Laura Ciudad, Adolfo Ruiz-Sanmartín, Mónica Martínez-Gallo, Ricard Ferrer, Juan Carlos Ruiz-Rodriguez, Javier Rodríguez-Ubreva, Roser Vento-Tormo, Esteban Ballestar
medRxiv 2022.10.24.22281485; doi: https://doi.org/10.1101/2022.10.24.22281485
Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines
Gerard Godoy-Tena, Anis Barmada, Octavio Morante-Palacios, Carlos de la Calle-Fabregat, Ricardo Martins-Ferreira, Anna G. Ferreté-Bonastre, Laura Ciudad, Adolfo Ruiz-Sanmartín, Mónica Martínez-Gallo, Ricard Ferrer, Juan Carlos Ruiz-Rodriguez, Javier Rodríguez-Ubreva, Roser Vento-Tormo, Esteban Ballestar
medRxiv 2022.10.24.22281485; doi: https://doi.org/10.1101/2022.10.24.22281485
Subject Area
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3235)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13252)
- Forensic Medicine (19)
- Gastroenterology (891)
- Genetic and Genomic Medicine (5066)
- Geriatric Medicine (471)
- Health Economics (773)
- Health Informatics (3190)
- Health Policy (1129)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (126)
- Nephrology (513)
- Neurology (4812)
- Nursing (254)
- Nutrition (716)
- Oncology (2484)
- Ophthalmology (703)
- Orthopedics (279)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (531)
- Pediatrics (1281)
- Primary Care Research (550)
- Public and Global Health (7374)
- Radiology and Imaging (1670)
- Respiratory Medicine (971)
- Rheumatology (473)
- Sports Medicine (416)
- Surgery (534)
- Toxicology (69)
- Transplantation (233)
- Urology (199)